NCT03945734

Brief Summary

This study examines the feasibility, cultural-sensitivity, and health effects of the expressive helping intervention by conducting a single-arm trial with Chinese-speaking cancer patients and survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 10, 2019

Completed
10 days until next milestone

Study Start

First participant enrolled

May 20, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

December 3, 2025

Status Verified

March 1, 2021

Enrollment Period

1.6 years

First QC Date

May 7, 2019

Last Update Submit

November 25, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Number of participants screened

    The number of participants screened for eligibility will be counted.

    through study completion, an average of 1 year

  • Compliance rate

    Compliance rate is calculated by dividing the number of writing/voice-recording sessions finished by the number of sessions assigned.

    through study completion, an average of 1 year

  • Retention rate

    Retention rate is calculated by dividing the number of participants who began the study by the number of participants who finished the entire study.

    through study completion, an average of 1 year

  • Meaningfulness of the study

    We will ask participants open-ended questions about whether they felt participating in this study was meaningful to them.

    This will be assessed approximately four weeks after the baseline

Secondary Outcomes (2)

  • Change in quality of life as assessed by the Functional Assessment of Cancer Therapy Scale (FACT).

    Baseline; 1-month follow-up; 3-month follow-up

  • Change in depressive symptoms as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D).

    Baseline; 1-month follow-up; 3-month follow-up

Study Arms (1)

Expressive Helping

EXPERIMENTAL

Participants complete four 20-minute writing/voice-recording sessions spaced one week apart. During the first week, the instructions will explain that cancer patients and survivors benefit from learning about other cancer survivors' experiences. They are told that the first three weeks of writing/voice-recording (writing/talking about their stress and coping at Week 1, deepest emotions about cancer at Week 2, self-affirmation and benefit finding at Week 3) are exercises designed to help them think about their cancer experiences and to prepare them to write/record the narrative they would share on Week 4. During Week 4, they are asked to write/record a narrative as if they are speaking to another Chinese person with cancer, adding advice and encouragements, and reminded that their writing/recording would be shared with other Chinese American cancer patients and survivors.

Behavioral: Expressive Helping

Interventions

Expressive helping harnesses the benefits of helping others (e.g., support giving) through writing or voice-recording. Expressive helping integrates two distinct areas of research showing that writing or speaking about ones' negative experiences and engaging in support giving behaviors can improve psychological well-being.

Expressive Helping

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of cancer (any type)
  • Of Chinese descent
  • Over the age of 18
  • Can speaking and read Mandarin Chinese

You may not qualify if:

  • Completed primary cancer treatment more than five years ago

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University

New York, New York, 10003, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2019

First Posted

May 10, 2019

Study Start

May 20, 2019

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

December 3, 2025

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations